Clinical Drug Experience Knowledgebase

abemaciclib (verzenio) (1 trial)

amoxicillin (1 trial)

carboplatin (paraplatin) (1 trial)

ciprofloxacin (cipro) (1 trial)

cmp-001 (1 trial)

dl-2-(difluoromethyl) ornithine (1 trial)

docetaxel (taxotere) (3 trials)

dutasteride (avodart) (1 trial)

enzalutamide (xtandi) (3 trials)

human fecal microbiota (Reybota) (1 trial)

ketoconazole (nizoral) (1 trial)

lapatinib (tykerb) (1 trial)

leuprolide (lupron) (1 trial)

luteinizing hormone (1 trial)

lutetium (177Lu) vipivotide tetraxetan (Pluvicto) (3 trials)

metronidazole (flagyl) (1 trial)

nivolumab (opdivo) (2 trials)

pembrolizumab (keytruda) (4 trials)

ptvg-ar (1 trial)

ptvg-hp (1 trial)

relugolix (ORGOVYX) (1 trial)

sargramostim (leukine) (2 trials)

satraplatin (1 trial)

seviteronel (1 trial)

talazoparib (talzenna) (1 trial)

telaglenastat (1 trial)

testosterone (delatestryl) (1 trial)

urea (1 trial)

vancomycin (Vancocin) (1 trial)

bicalutamide (casodex) (1 trial)

burixafor (1 trial)

cemiplimab (libtayo) (1 trial)

degarelix acetate (firmagon) (1 trial)

ipilimumab (yervoy) (2 trials)

neoantigen dna vaccine (1 trial)

prostvac-v/tricom (1 trial)

radium-223 (xofigo) (1 trial)

tmpsma-02 car t cells (1 trial)

cabozantinib (cometriq) (1 trial)